Literature DB >> 22802582

Normal reference values for glomerular filtration rate: what do we really know?

Pierre Delanaye1, Elke Schaeffner, Natalie Ebert, Etienne Cavalier, Christophe Mariat, Jean-Marie Krzesinski, Olivier Moranne.   

Abstract

In nephrology, chronic kidney disease is defined by both proteinuria and measurement of glomerular filtration rate (GFR). This article focuses on GFR and different ways to define its normal reference values. In this context, we compare two perspectives: first the reference values defined by measuring GFR in normal individuals (the 'classical way') and secondly a fixed cut-off value at 60 mL/min/1.73 m2 according to the associated mortality risk (the 'prognostic way'). Following the classical way, we can assert that normal GFR values are largely over 60 mL/min/1.73 m2 in healthy subjects, at least before the age of 70 years. However, we know that GFR physiologically decreases with age, and in adults older than 70 years, values below 60 mL/min/1.73 m2 could be considered normal. Following the 'prognostic way', the fixed cut-off of 60 mL/min/1.73 m2 has been retained in the K-DIGO guidelines. However, we challenge this concept and the fact that the variable 'age' is poorly taken into account in these data. There is an obvious discrepancy between the reference values defined either by the 'classical way' or by the 'prognostic way' which we think could be largely reduced, if age was better taken into consideration in these definitions.

Entities:  

Mesh:

Year:  2012        PMID: 22802582     DOI: 10.1093/ndt/gfs265

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  48 in total

1.  Lifetime Risk of CKD: What Does It Really Mean?

Authors:  Pierre Delanaye; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

Review 2.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

3.  Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.

Authors:  Erik Holzwirth; Jelena Kornej; Sandra Erbs; Danilo Obradovic; Andreas Bollmann; Gerhard Hindricks; Holger Thiele; Petra Büttner
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

4.  GFR estimating equations: getting closer to the truth?

Authors:  Andrew D Rule; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

Review 5.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

6.  An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.

Authors:  Pierre Delanaye; Richard J Glassock; Hans Pottel; Andrew D Rule
Journal:  Clin Biochem Rev       Date:  2016-02

7.  Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2).

Authors:  Hans Pottel; Liesbeth Hoste; Pierre Delanaye
Journal:  Pediatr Nephrol       Date:  2014-11-19       Impact factor: 3.714

8.  GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.

Authors:  Bjørn O Eriksen; Runolfur Palsson; Natalie Ebert; Toralf Melsom; Markus van der Giet; Vilmundur Gudnason; Olafur S Indridason; Lesley A Inker; Trond G Jenssen; Andrew S Levey; Marit D Solbu; Hocine Tighiouart; Elke Schaeffner
Journal:  J Am Soc Nephrol       Date:  2020-06-04       Impact factor: 10.121

9.  Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.

Authors:  Lesley A Inker; Hocine Tighiouart; Thor Aspelund; Vilmundur Gudnason; Tamara Harris; Olafur S Indridason; Runolfur Palsson; Shani Shastri; Andrew S Levey; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

Review 10.  [Renal replacement therapy in the elderly].

Authors:  R Schindler
Journal:  Z Gerontol Geriatr       Date:  2016-07-21       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.